Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta1.05
Shares Outstanding181.3M
Average Volume (10 days)955.4K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.67
Sales (TTM)$10.19
Book Value (MRQ)$17.85
Cash Flow (TTM)$0.77
Cash (MRQ)$1,380,372,000.00

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy15
 
Buy1
 
Hold3
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Michael G. Grey
(2,500)
Sell
Aug 3, 2020
Henry J. Fuchs
President, Worldwide R&D
(126,389)
Sell
Jul 20, 2020
Andrea Acosta
GVP, Chief Accounting Officer
(285)
Dispose
Jul 17, 2020
Andrea Acosta
GVP, Chief Accouning Officer
(285)
Dispose
Jul 17, 2020
Henry J. Fuchs
President, Worldwide R&D
(23,011)
Sell
Jul 13, 2020

Recent SEC Filings

Insider Buy/Sell
Aug 5, 2020
Quarterly Financials
Aug 5, 2020
Company Events
Aug 4, 2020
New Insider
Jul 22, 2020
Insider Buy/Sell
Jul 22, 2020

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information